Google Play icon

Genome screen uncovers new targets for cancer immunotherapy

Posted August 26, 2019

Immunotherapy has revolutionized the treatment of cancer in the last decade, yet many tumors do not respond to these new therapies. A new genome-wide screen of 20,000 human genes in T cells have turned up several new candidates to unleash the immune system’s ability to attack a variety of tumor types, Yale researchers report in the journal Cell.

Immunotherapy is not effective in all patients and 70% to 80% don’t respond to treatment,” said Yale’s Sidi Chen, assistant professor of genetics and senior author of the study. “We asked: Why don’t we take one gene at a time and see which ones are responsible for tumor growth and might be targets for new therapies?”

Vacutainers for blood testing. Image credit: George Hodan via, CC0 Public Domain

Vacutainers for blood testing. Image credit: George Hodan via, CC0 Public Domain

Many immunotherapy treatments are based on inhibiting the gene PD1, which suppresses the ability of T cells to mobilize and attack cancer tumors. These therapies have dramatically increased survival of patients with some types of cancers, such as melanoma and lung cancer. Yet even in these cancers, only 30% to 40% of patients respond to immunotherapy alone. For most cancer types, the response rates are below 20% — and below 10% for some aggressive tumors.

The new platform developed at Yale utilizes CRISPR gene editing technology to knock out genes individually in mice to see which ones might have biggest impact on the immune system’s response to tumors. One of genes identified in the new research, DHX37, was found to suppress the response of CD8 “killer” T cells to tumors in mice. The researchers showed that mice bred to have triple negative breast cancer showed a significant reduction of tumors when DHX37 was edited from their genomes.

Once we eliminated this brake on the immune system, the killer T cells could go crazy attacking tumors,” Chen said.

Chen said his laboratory is now studying several other genes discovered during the screens to assess their impact on various types of tumors and developing new immunotherapeutic agents against these targets.

Source: Yale University

Featured news from related categories:

Technology Org App
Google Play icon
85,538 science & technology articles

Most Popular Articles

  1. New treatment may reverse celiac disease (October 22, 2019)
  2. The World's Energy Storage Powerhouse (November 1, 2019)
  3. "Helical Engine" Proposed by NASA Engineer could Reach 99% the Speed of Light. But could it, really? (October 17, 2019)
  4. Universe is a Sphere and Not Flat After All According to a New Research (November 7, 2019)
  5. Plastic waste may be headed for the microwave (October 18, 2019)

Follow us

Facebook   Twitter   Pinterest   Tumblr   RSS   Newsletter via Email